MABVAX THERAPEUTICS HOLDINGS, INC. 4
4 · MABVAX THERAPEUTICS HOLDINGS, INC. · Filed Apr 11, 2017
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2017-04-11$2.00/sh−200$400→ 22,595 total - Sale
Common Stock
2017-04-10$2.00/sh−400$800→ 22,795 total - Sale
Common Stock
2017-04-07$2.00/sh−450$902→ 23,195 total
Footnotes (2)
- [F1]Represents a portion of the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II of the reporting person's Form 4, as filed with the Securities and Exchange Commission on April 4, 2017. This sale is mandated by the Issuer's election under the equity incentive plan to require satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2 to $2.01 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.